Last week, Dr David Bruce of Symbio Proinnovera attended FACE CONFERENCE 2024 at the prestigious Business Design Centre located in the heart of London, UK. This year's revamped FACE conference was the perfect place for physicians and aesthetic professionals to discuss innovations in aesthetics and dermal fillers. Dave was fortunate enough to have over 20 very good quality meetings during the 2-day conference and looks forward to attending next year's FACE 2025! #FACE2024 #aesthetics #dermalfillers #CRO
Proinnovera - Part of Symbio Proinnovera
Arzneimittelherstellung
Muenster, NRW 1.461 Follower:innen
Performance for People - Transforming Expertise and Connecting People
Info
At Proinnovera we transform over 25 years of dermatological experience into clinical trial excellence in the field of inflammatory diseases as a full-services CRO. We match our talent and experience with the latest innovative technologies to leverage clinical trial execution. Hands on, efficient, and with one goal; to deliver measurable performance in everything we do and for everyone we work with. Performance for People! Proinnovera is worldwide leader in conducting dermatology trials, but is also experienced in the following areas: - Dermatology & Aesthetics - Inflammatory Diseases - Oncology - Allergology We are an independently owned, mid-sized CRO with offices in Germany, Poland, Czech Republic and USA, offering full-service coverage and expertise in the largest clinical dermatology markets in the world. For more information, please contact us at information@proinnovera.com .
- Website
-
http://www.proinnovera.com
Externer Link zu Proinnovera - Part of Symbio Proinnovera
- Branche
- Arzneimittelherstellung
- Größe
- 51–200 Beschäftigte
- Hauptsitz
- Muenster, NRW
- Art
- Privatunternehmen
- Gegründet
- 1997
- Spezialgebiete
- Project Management, Medical writing, Studies concerning medical devices, Quality assurance in clinical research, GCP-Training for study personnel, Regulatory Affairs, Patient Recruitment, Clinical Monitoring, Safety Management, Dermatology, Dermatology Clinical Trial Services, Clinical Trials, Recruitment & Feasibility, Clinical Trial Consultancy, Study Design and Protocol Writing und Data Management
Orte
-
Primär
Wienburgstrasse 207
Muenster, NRW 48159, DE
-
1800 Sir Tyler Dr
Wilmington, North Carolina 28405, US
-
Ulica Chmielna 73B
14
Warsaw, Warsaw 00-801, PL
-
Havanska 1087
3a
Prague, Prague 17000, CZ
Beschäftigte von Proinnovera - Part of Symbio Proinnovera
-
Debra Barrette
Clinical Research Consultant - Clinical Research Monitoring & BioPharma/ Pharma Global Talent Acquisition
-
Michael Childress
Lead Sr. Clinical Research Associate at proinnovera - International Dermatology CRO
-
Dr. med. Edis Gasanin, MHBA
Deputy Medical Director
-
Mike Vellmanns
Head of Project Management bei Proinnovera GmbH
Updates
-
Global CRO Symbio Proinnovera is excited to announce their second podcast edition, "Dermatology and Research with Dr. Sunil Dhawan", in the Pharma Talk Podcast series. 🎙 This episode, featuring Sunil Dhawan, MD from Center for Dermatology, discusses how he got started in clinical research. Dr. Dhawan, talks about the studies he enjoys doing and ones that are more challenging. Being one of the top dermatology sites in the country, Dr Dhawan shares a wealth of valuable information and insights from an investigator's perspective. In addition, Dr. Dhawan is involved in two new ventures and discusses how they can improve the clinical trial process. Hope you enjoy the podcast ! https://lnkd.in/e46ME9vC 🌏💊 #clinicaltrials #globalcro #investigators #dermatology
Symbio Proinnovera "Pharma Talk" Podcast: Episode #2 Sunil Dhawan, MD. Dermatology & Research
https://www.youtube.com/
-
Only three days away, our colleagues Julia Hoppstädter and Dave Bruce with Symbio Proinnovera will be attending the EAACI Congress in Valencia, Spain. Both Julia and David are eager and excited to network, engage and share insights with many knowledgeable and dedicated industry professionals. Please feel free to reach out to them—they look forward to meeting you in Spain! #EAACI#AllergyClinicalImmunology#Dermatology#CRO
-
-
🌟 Happy Clinical Trials Day! 🧪🔬 Today, May 20th, we celebrate Clinical Trials Day. 🌿 Why Celebrate? Clinical trials are the engines that power the advancement of human health. They pave the way for groundbreaking treatments, life-saving drugs, innovative therapies and improving the health outcomes of patients. From the first clinical trial in 1747 to today’s cutting-edge studies, these efforts shape the future of medicine. 💡 👏 Thank You, Clinical Research Professionals! Today we honor and extend our appreciation to the clinical research professionals who work tirelessly to advance the field of medicine. Your dedication and hard work are truly commendable. Also, thankful to the individuals who participate in these clinical trials. Let's continue to celebrate and support the efforts of clinical research professionals. Happy Clinical Trials Day! #ClinicalTrialsDay#ACRP#ClinicalResearch
-
-
We are excited to announce our colleagues Julia Hoppstädter and Dave Bruce with Symbio Proinnovera will be attending the EAACI Congress in Valencia, Spain. This prestigious congress brings together researchers and experts in the field of allergy and clinical immunology. Julia and David are looking forward to meeting knowledgeable and dedicated industry professionals, representatives and clinicians from around the world, collaborating and sharing the latest breakthroughs, and innovations in their field. Please feel free to reach out to us—we look forward to meeting you! #EAACI#AllergyClinicalImmunology#Dermatology#CRO
-
-
We're thrilled to announce that our latest whitepaper "Industry and Clinical Trends in Dermal Filler" is now available on our website! 🎉
Dermal fillers are high-risk medical devices that must undergo pivotal clinical investigations, with a design and scope similar to that of Phase III studies for drug/medicinal product approval. Symbio Proinnovera has conducted investigations that have resulted in the approval of well-known dermal fillers in the US and in Europe. Request our white paper “Industry and Clinical Trends in Dermal Fillers” from our website now. https://lnkd.in/euEUKcuM
-
-
May is National Skin Cancer Awareness Month, and a reminder to all to take skin health seriously this year. Every year, over 8,000 die of melanoma, which is treatable when caught early. The American Academy of Dermatology recommends a life-long habit of screening your skin for potential cancers; you can sign up for the AAD's free skin cancer screening or see a local dermatologist. Additionally, as we move into the summer months in the northern hemisphere, remember to practice safe sun practices to keep your skin healthy and young for the future to come! For more information, visit the AAD's webpage: https://lnkd.in/epVxZwtz #skincancerawareness ☀
May is Skin Cancer Awareness Month
aad.org
-
Dr. Peter Bernthaler and Julia Hoppstädter with Symbio Proinnovera reflecting on a fantastic 5th Dermatology Drug Development Summit Europe in Berlin! They are grateful for the insightful discussions, innovative talks, and valuable connections made during the event. Looking forward to returning to the DDDS in Boston! #ClinicalTrials #Dermatology
-
-
Happy to connect at the upcoming 5th Dermatology Drug Development Summit, April 16-18 in Berlin. 🌟
Symbio Proinnovera is excited to attend the upcoming 5th Dermatology Drug Development Summit Europe, April 16-18 in Berlin. Our colleagues Dr. Peter Bernthaler and Julia Hoppstädter are eager to meet with industry leaders and discuss how we can help achieve their clinical research goals. Please reach out, we would love to connect ! #ClinicalTrials #Dermatology
-